Sofía D. Merajver

20.8k total citations
259 papers, 12.2k citations indexed

About

Sofía D. Merajver is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sofía D. Merajver has authored 259 papers receiving a total of 12.2k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Molecular Biology, 95 papers in Oncology and 73 papers in Cancer Research. Recurrent topics in Sofía D. Merajver's work include BRCA gene mutations in cancer (50 papers), Breast Cancer Treatment Studies (30 papers) and Cancer Genomics and Diagnostics (28 papers). Sofía D. Merajver is often cited by papers focused on BRCA gene mutations in cancer (50 papers), Breast Cancer Treatment Studies (30 papers) and Cancer Genomics and Diagnostics (28 papers). Sofía D. Merajver collaborates with scholars based in United States, Egypt and Ghana. Sofía D. Merajver's co-authors include Celina G. Kleer, Luc Van Kaer, George J. Brewer, Zhi-Fen Wu, Quintin Pan, Alejandra C. Ventura, Quintin Pan, Li Bao, Theodoros N. Teknos and Mousumi Banerjee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Physical Review Letters.

In The Last Decade

Sofía D. Merajver

251 papers receiving 11.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sofía D. Merajver United States	62	5.5k	4.7k	3.4k	2.2k	1.2k	259	12.2k
Yixin Wang China	54	4.6k 0.8×	3.7k 0.8×	3.2k 0.9×	1.0k 0.5×	1.1k 0.9×	362	13.9k
Michael S. Pepper South Africa	75	11.0k 2.0×	4.8k 1.0×	4.6k 1.3×	1.6k 0.7×	1.3k 1.1×	346	20.9k
Robert B. Clarke United Kingdom	54	5.6k 1.0×	5.8k 1.2×	2.6k 0.8×	2.2k 1.0×	645 0.5×	168	13.7k
Sara Gandini Italy	62	3.7k 0.7×	7.0k 1.5×	2.1k 0.6×	1.4k 0.6×	2.6k 2.2×	363	16.3k
Robert I. Nicholson United Kingdom	74	8.1k 1.5×	9.4k 2.0×	4.3k 1.2×	4.9k 2.2×	1.3k 1.1×	262	18.4k
Kenneth H. Cowan United States	61	7.6k 1.4×	6.1k 1.3×	1.9k 0.6×	2.1k 0.9×	1.0k 0.9×	195	13.4k
Rulla M. Tamimi United States	66	3.3k 0.6×	6.7k 1.4×	3.9k 1.1×	2.5k 1.1×	1.8k 1.5×	420	15.8k
Alan Cantor United States	69	6.9k 1.3×	4.6k 1.0×	2.9k 0.8×	1.7k 0.8×	2.1k 1.7×	286	17.8k
Shuang Huang China	60	7.5k 1.4×	2.4k 0.5×	2.7k 0.8×	1.2k 0.5×	993 0.8×	308	12.9k
Jenny C. Chang United States	61	6.0k 1.1×	6.8k 1.5×	4.7k 1.4×	1.7k 0.8×	1.1k 1.0×	219	14.0k

Countries citing papers authored by Sofía D. Merajver

Since Specialization

Citations

This map shows the geographic impact of Sofía D. Merajver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofía D. Merajver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofía D. Merajver more than expected).

Fields of papers citing papers by Sofía D. Merajver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofía D. Merajver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofía D. Merajver. The network helps show where Sofía D. Merajver may publish in the future.

Co-authorship network of co-authors of Sofía D. Merajver

This figure shows the co-authorship network connecting the top 25 collaborators of Sofía D. Merajver. A scholar is included among the top collaborators of Sofía D. Merajver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofía D. Merajver. Sofía D. Merajver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boggan, James E., Blair Richards, Kara J. Milliron, et al.. (2025). Reclassification of variants of uncertain significance by race, ethnicity, and ancestry for patients at risk for breast cancer. Frontiers in Oncology. 15. 1455509–1455509. 2 indexed citations

Kozminsky, Molly, Kathleen C. Day, Rebecca Tagett, et al.. (2024). Characterization of circulating tumor cells in patients with metastatic bladder cancer utilizing functionalized microfluidics. Neoplasia. 57. 101036–101036. 1 indexed citations

Laws, Alison, Eshita Sharma, Kara J. Milliron, et al.. (2024). Upgrade Rates and Breast Cancer Development Among Germline Pathogenic Variant Carriers with High-Risk Breast Lesions. Annals of Surgical Oncology. 31(5). 3120–3127. 1 indexed citations

Morikawa, Aki, Aaron M. Udager, Liwei Bao, et al.. (2023). Personalized medicine for brain metastases (BrMets) through patient-derived organoid (PDO) drug testing.. JCO Global Oncology. 9(Supplement_1). 11–11.

Yates, Joel A., Megan Altemus, Liwei Bao, et al.. (2023). Blood–Brain Barrier Remodeling in an Organ‐on‐a‐Chip Device Showing Dkk1 to be a Regulator of Early Metastasis. SHILAP Revista de lepidopterología. 3(4). 9 indexed citations

Jiagge, Evelyn, Ernest Adjei, Susan K. Foltin, et al.. (2019). Clinical characteristics, HIV status, and molecular biomarkers in squamous cell carcinoma of the conjunctiva in Ghana. Health Science Reports. 2(2). e108–e108. 8 indexed citations

Rosselli‐Murai, Luciana K., Joel A. Yates, Sei Yoshida, et al.. (2018). Loss of PTEN promotes formation of signaling-capable clathrin-coated pits. Journal of Cell Science. 131(8). 30 indexed citations

Katapodi, Maria C., Miyeon Jung, Ann Schafenacker, et al.. (2018). Development of a Web-based Family Intervention for BRCA Carriers and Their Biological Relatives: Acceptability, Feasibility, and Usability Study. JMIR Cancer. 4(1). e7–e7. 18 indexed citations

González, Maria E., et al.. (2011). Histone Methyltransferase EZH2 Induces Akt-Dependent Genomic Instability and BRCA1 Inhibition in Breast Cancer. Cancer Research. 71(6). 2360–2370. 89 indexed citations

10.

Rosenthal, Devin T., Silvia Escudero, Liwei Bao, et al.. (2011). p38γ Promotes Breast Cancer Cell Motility and Metastasis through Regulation of RhoC GTPase, Cytoskeletal Architecture, and a Novel Leading Edge Behavior. Cancer Research. 71(20). 6338–6349. 49 indexed citations

11.

Iniesta, Maria D., et al.. (2010). One-Hit Effects and Cancer. Cancer Prevention Research. 3(1). 12–15. 3 indexed citations

12.

Dawood, Shaheenah, Sofía D. Merajver, Patrice Viens, et al.. (2010). International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Annals of Oncology. 22(3). 515–523. 331 indexed citations

13.

Liu, Suling, Christophe Ginestier, Emmanuelle Charafe‐Jauffret, et al.. (2008). BRCA1 regulates human mammary stem/progenitor cell fate. Proceedings of the National Academy of Sciences. 105(5). 1680–1685. 336 indexed citations

14.

Merajver, Sofía D., et al.. (2008). Molecular determinants of the inflammatory breast cancer phenotype.. PubMed. 22(14). 1556–61; discussion 1561, 1565. 12 indexed citations

15.

Huang, Wei, Yanhong Zhang, Sooryanarayana Varambally, et al.. (2008). Inhibition of CCN6 (Wnt-1-Induced Signaling Protein 3) Down-Regulates E-Cadherin in the Breast Epithelium through Induction of Snail and ZEB1. American Journal Of Pathology. 172(4). 893–904. 54 indexed citations

16.

Evelyn, Chris R., Susan M. Wade, Qin Wang, et al.. (2007). CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling. Molecular Cancer Therapeutics. 6(8). 2249–2260. 175 indexed citations

17.

Elstrodt, Fons, Antoinette Hollestelle, Jord H.A. Nagel, et al.. (2006). BRCA1 Mutation Analysis of 41 Human Breast Cancer Cell Lines Reveals Three New Deleterious Mutants. Cancer Research. 66(1). 41–45. 215 indexed citations

18.

Ding, Lei, Christine A. Erdmann, Arul M. Chinnaiyan, Sofía D. Merajver, & Celina G. Kleer. (2006). Identification of EZH2 as a Molecular Marker for a Precancerous State in Morphologically Normal Breast Tissues. Cancer Research. 66(8). 4095–4099. 102 indexed citations

19.

Kent, Michael S., Bruce R. Madewell, Gillian Dank, et al.. (2004). An anticopper antiangiogenic approach for advanced cancer in spontaneously occurring tumors using tetrathiomolybdate: A pilot study in a canine animal model. The Journal of Trace Elements in Experimental Medicine. 17(1). 9–20. 19 indexed citations

20.

Kleer, Celina G., Luc Van Kaer, Thomas Braun, & Sofía D. Merajver. (2001). Persistent E-Cadherin Expression in Inflammatory Breast Cancer. Modern Pathology. 14(5). 458–464. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact